VVVVVVVV Trademark
Trademark Overview
On Tuesday, February 27, 2024, a trademark application was filed for VVVVVVVV with the United States Patent and Trademark Office. The USPTO has given the VVVVVVVV trademark a serial number of 98423637. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 6, 2025. This trademark is owned by Veda Life Sciences, Inc.. The VVVVVVVV trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Platform as a service (PAAS) featuring computer software platforms for use in providing back-end automation features to assist in onboarding new clinical trial sites and healthcare providers for facilitating and enabling recruitment of participants for use in running, managing and analyzing clinical trials, namely enabling providers to create and scale clinical research capabilities and bring scientific advancements to patients that need them most; Platform as a service (PAAS) featuring computer software platforms for management and/or participation in clinical research in the nature of database creation and management, viewing data analytics, enabling site data capture, conducting virtual visits through telehealth video calls, selecting configurable data collection methods with configurable options, configuring a participant- facing website to recruit and screen participants for eligibility; Platform as a service (PAAS) featuring computer software platforms for automating workflows ar...
General Information
Serial Number | 98423637 |
Word Mark | VVVVVVVV |
Filing Date | Tuesday, February 27, 2024 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, May 6, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, May 6, 2025 |
Trademark Statements
Description of Mark | The mark consists of the stylized drawing of a starburst wherein the border is comprised of eight stylized "V" letters. |
Pseudo Mark | VEDA |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Platform as a service (PAAS) featuring computer software platforms for use in providing back-end automation features to assist in onboarding new clinical trial sites and healthcare providers for facilitating and enabling recruitment of participants for use in running, managing and analyzing clinical trials, namely enabling providers to create and scale clinical research capabilities and bring scientific advancements to patients that need them most; Platform as a service (PAAS) featuring computer software platforms for management and/or participation in clinical research in the nature of database creation and management, viewing data analytics, enabling site data capture, conducting virtual visits through telehealth video calls, selecting configurable data collection methods with configurable options, configuring a participant- facing website to recruit and screen participants for eligibility; Platform as a service (PAAS) featuring computer software platforms for automating workflows around patient communication, data entry, regulatory management and clinical trial operations use in facilitating and managing compliance and enabling preparation of new study trial sites for use in bringing trained clinical research coordinators together with community managers to run clinical trials at scale; Providing a website featuring online non-downloadable software for engaging community- based healthcare organizations and clinical trial sponsors for use in clinical research analytics, data capture forms, telehealth, electronic clinical outcome assessment, recruitment, and electronic consent; Providing information in the field of clinical research via a website; Providing medical and scientific research information in the field of clinical trials; Consulting services for others in the field of design, planning, and implementation project management of clinical trials |
Classification Information
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, February 27, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Veda Life Sciences, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Frederick, MD 21704 |
Party Name | Veda Life Sciences, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Frederick, MD 21704 |
Trademark Events
Event Date | Event Description |
Monday, July 8, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Tuesday, February 27, 2024 | NEW APPLICATION ENTERED |
Monday, July 8, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, September 19, 2024 | NON-FINAL ACTION WRITTEN |
Thursday, September 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, September 16, 2024 | ASSIGNED TO EXAMINER |
Thursday, September 19, 2024 | NON-FINAL ACTION E-MAILED |
Friday, December 6, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, December 6, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, December 6, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, February 24, 2025 | FINAL REFUSAL E-MAILED |
Monday, February 24, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Monday, February 24, 2025 | FINAL REFUSAL WRITTEN |
Saturday, March 29, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Saturday, March 29, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Saturday, March 29, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, April 3, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, April 30, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 6, 2025 | PUBLISHED FOR OPPOSITION |
Tuesday, May 6, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |